[The Place of Death of Neurological Patients with Selected Disease Entities: Data from an Observational Study on Places of Death from Germany]. / Der Sterbeort neurologischer Patienten mit ausgewählten Erkrankungsentitäten: Daten einer Beobachtungsstudie zu Sterbeorten aus Deutschland.
Fortschr Neurol Psychiatr
; 90(10): 447-455, 2022 Oct.
Article
em De
| MEDLINE
| ID: mdl-34844276
ABSTRACT
BACKGROUND:
So far, there are only few data on places where neurological patients die in Germany.METHODS:
In the context of the most comprehensive study on the place of death in Germany to date, the present investigation examined the place of death of neurological patients with selected disease entities (ALS (ALS), malignant neoplasm of the brain (BNG), brain metastasis(es) (HM), hypoxic brain damage after resuscitation (HHS), non-traumatic SAB (SAB), dementia (≥65 years) (DEM)). All death certificates issued in the city of Münster of 2017 were evaluated. Patients were identified on the basis of the medical information on the cause of death.RESULTS:
A total of 3,844 people died, including neurological patients with the following disease entities ALS (6), BNG (29), HM (102), HHS (54), SAB (20), DEM (485). The distribution of places of death was as follows (AS, BNG, HM, HHS, SAB, DEM;%) home 50.0/10.3/13.7/1.9/0.0/12.0; hospital 33.3/48.3/38.2/90.7/100/23.1; intensive care unit 0.0/6.9/5.9/61.1/65.0/2.7; palliative care unit 33.3/0.0/6.9/0.0/0.0/1.4; hospice 16.7/27.6/43.1/0.0/0.0/1.2; nursing home 0.0/13.8/4.9/7.4/0.0/63.7; other places 0.0/0.0/0.0/0.0/0.0/0.0.CONCLUSION:
The most common place of death of neurological patients with selected disease entities is as follows ALS>home, malignant brain tumour>hospital, brain metastasis(es)>hospice, hypoxic brain injury after resuscitation>hospital, non-traumatic SAB>hospital, dementia patients (≥65 years)>nursing home.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Assistência Terminal
/
Neoplasias Encefálicas
/
Demência
/
Serviços de Assistência Domiciliar
/
Esclerose Lateral Amiotrófica
Tipo de estudo:
Observational_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
De
Ano de publicação:
2022
Tipo de documento:
Article